107 related articles for article (PubMed ID: 25168539)
1. Hyperuricemia: a possible cause of hemospermia.
Kurkar A; Elderwy AA; Awad SM; Abulsorour S; Aboul-Ella HA; Altaher A
Urology; 2014 Sep; 84(3):609-12. PubMed ID: 25168539
[TBL] [Abstract][Full Text] [Related]
2. Hemospermia: review of the management with 5 years follow-up.
Kochakarn W; Leenanupunth C; Ratana-Olarn K; Viseshsindh V
J Med Assoc Thai; 2001 Nov; 84(11):1518-21. PubMed ID: 11853292
[TBL] [Abstract][Full Text] [Related]
3. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
4. Finasteride for treatment of refractory hemospermia: prospective placebo-controlled study.
Badawy AA; Abdelhafez AA; Abuzeid AM
Int Urol Nephrol; 2012 Apr; 44(2):371-5. PubMed ID: 21956168
[TBL] [Abstract][Full Text] [Related]
5. Transurethral seminal vesiculoscopy in the diagnosis and treatment of persistent or recurrent hemospermia: a single-institution experience.
Liu ZY; Sun YH; Xu CL; Hou JG; Gao X; Lu X; Ye HM; Wang LH; Gao XF
Asian J Androl; 2009 Sep; 11(5):566-70. PubMed ID: 19701221
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
7. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry.
Málek F; Ošťádal P; Pařenica J; Jarkovský J; Vítovec J; Widimský P; Linhart A; Fedorco M; Coufal Z; Miklík R; Krűger A; Vondraková D; Špinar J
J Crit Care; 2012 Dec; 27(6):737.e11-24. PubMed ID: 22699032
[TBL] [Abstract][Full Text] [Related]
8. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
[TBL] [Abstract][Full Text] [Related]
9. [Hemospermia: cause, clinical significance and our experience].
Sampalmieri G; Giancola FL; Cabras A
Riv Eur Sci Med Farmacol; 1992; 14(2):135-7. PubMed ID: 1484985
[TBL] [Abstract][Full Text] [Related]
10. [Hemospermia].
Klevecka V; Jatulis A; Kraniauskas V; Salkauskas V; Uksas A; Zeromskas P
Medicina (Kaunas); 2005; 41(4):359-64. PubMed ID: 15864011
[TBL] [Abstract][Full Text] [Related]
11. J-shaped mortality relationship for uric acid in CKD.
Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
[TBL] [Abstract][Full Text] [Related]
12. [Transurethral seminal vesiculoscopy for refractory or recurrent hemospermia: clinical analysis of 162 cases].
Wang L; Liu ZY; Xu CL; Sun YH; Wan P; Sheng X; Xiao L; Piao SG; Ye HM; Lu X
Zhonghua Nan Ke Xue; 2013 Jun; 19(6):531-4. PubMed ID: 23862232
[TBL] [Abstract][Full Text] [Related]
13. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach.
Hsu HH; Chan YL; Huang CC
J Nephrol; 2004; 17(1):50-6. PubMed ID: 15151259
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations of patients with hyperuricemia.
Akkasilpa S; Avihingsanon Y; Hanvivadhanakul P; Wonchinsri J
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S41-4. PubMed ID: 16083159
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
[TBL] [Abstract][Full Text] [Related]
16. Gout in renal allograft recipients according to the pretransplant hyperuricemic status.
Hernández-Molina G; Cachafeiro-Vilar A; Villa AR; Alberú J; Rull-Gabayet M
Transplantation; 2008 Dec; 86(11):1543-7. PubMed ID: 19077887
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis.
Xia X; He F; Wu X; Peng F; Huang F; Yu X
Am J Kidney Dis; 2014 Aug; 64(2):257-64. PubMed ID: 24176223
[TBL] [Abstract][Full Text] [Related]
18. Hemospermia.
Ahmad I; Krishna NS
J Urol; 2007 May; 177(5):1613-8. PubMed ID: 17437771
[TBL] [Abstract][Full Text] [Related]
19. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
Whelton A; MacDonald PA; Chefo S; Gunawardhana L
Postgrad Med; 2013 Jan; 125(1):106-14. PubMed ID: 23391676
[TBL] [Abstract][Full Text] [Related]
20. [Etiological diagnosis and management of hemospermia].
Chen ZF
Zhonghua Nan Ke Xue; 2008 Oct; 14(10):867-70. PubMed ID: 19157091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
